1Hausfater EGarric S,Ayed S,et al. Usefulness of procalcitonin as amarker of systemic infection in emergency department patients: a prospective study[J].Clin infect Dis, 2002,34(7):895-901.
1Snider RH Jr, Nylen ES, Becket KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization[J]. J Investig Med, 1997,45(9) :552-560.
2Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the caleitonink-1 gene in multiple tissues in response to sepsis[J]. J Clin Endocrinol Metab, 2001,86( 1 ) :396-404.
3Oberhoffer M, Stonans I, Russwt, rm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitra[J]. J Lab Clin Med, 1999.134(1 ) :49-55.
4Whang KT, Vath SD,Becker KL, et al.Procalcitoin and proinflammatory cytokine interactions in sepsis[ J].Shock, 2000,14(1 ) :73-78.
5Nylen ES, Whang KT, Snider RH Jr, et al. Mortality is increased byprocalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[ J]. Crit Care Med, 1998,26 (6) : 1001-1006.
6Martinez JM, Becket KL, Mailer B, et al. Improved physiologic and metabolic parameters and increased survival with late procaleiton in immunoneutralization in septic pigs. In : 41 st Interscience Conference on Antimicrehiol Agents and Chemotherapy (ICAAC). Chicago, IL,2001.
7Brunkhorst FM, Heins U, Forycki ZF. Kinetics of pmcalcitonin in iatrogenic sepsis[ J]. Intensive Care Med, 1998,24(8) :888-889.
8Schroder J, Staubach KH, Zabel P, et al. Procalcitonin as a marker of severity in septic shock[J]. Langenbecks Arch Sum. 384( 1 ) :33-38.
9Marchini G, Berggren V, Djilalik-Merzoug R, et al. The birth process initiates an acute phase reaction in the fetus-newbom infant[J]. Aeta Paediatr, 2000, 89(9):1082-1086.
10Maire F, Heraud MC, Lorlette Y, et al. The value of procaleitonin in neonatal infecfion[J]. Arch Pediatr, 1999,6(5) :503-509.
5Gharaibeh KI,Qasaimeh GR,AI-Heiss H,et al.Effect of timing of surgery,type of inflammation,and sex on outcome of laparoscopic cholecystectomy for acute cholecystitis[J].Laparoendese Adv Surg Tech A,2002,12(3):193-198.
6Kimura Y,Takada T,Kawarada Y,et al.Definitions,pathophysiology,and epidemiology of acute cholangitis and choleeystitis:Tokyo guidelines[J].Hepatobiliary Pancreat Surg,2007,14(1):15-26.
7Hengst JM.The role of C-reactive protein in the evaluation and management of infants with suspected sepsis[J].Adv Neonatal Care,2003,3(1):3-13.
8Povoa P,Almeida E,Moreira P,et al.C-reactive protein as an indicator of sepsis[J].Intensive Care Med,1998,24(10):1052-1056.
9Yentis S M,Soni N,Sheldon J.C-reactive protein as an indicator of res01ution of sepsis in the intensive care unit[J].Intensive Care Med,1995,21(7):602-605.
10Matson A,Soni N,Sheldon J.C-reactive protein as a diagnostic test of sepsis in the critically ill[J].Anaesth IntensiveCare,1991,19(2):182-186.
